From: Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
Characteristics | ESR+ | ESR− | P value |
---|---|---|---|
No. of cases (%) | |||
Age (years) | |||
≤ 60 | 37 | 77 | 0.849 |
> 60 | 23 | 45 | |
Sex | |||
Male | 36 | 74 | 0.932 |
Female | 24 | 48 | |
Stage | |||
III-IV | 48 | 63 | 0.0002 |
I-II | 12 | 59 | |
Myc | |||
Positive | 28 | 32 | 0.006 |
Negative | 32 | 90 | |
ECOG PS | |||
≥ 2 | 20 | 10 | < 0.0001 |
< 2 | 40 | 112 | |
LDH | |||
Over ULN | 47 | 37 | < 0.0001 |
normal | 13 | 85 | |
ENI | |||
≥ 2 | 21 | 24 | 0.024 |
< 2 | 39 | 98 | |
Bcl2 | |||
≥ 70% | 30 | 56 | 0.603 |
< 70% | 30 | 66 | |
IPI | |||
3–5 | 31 | 19 | < 0.0001 |
0–2 | 29 | 103 | |
B symptoms | |||
Positive | 43 | 42 | < 0.0001 |
Negative | 17 | 80 | |
COO (Hans) | |||
GCB | 13 | 60 | 0.0004 |
Non-GCB | 47 | 62 | |
DEL | |||
Positive | 14 | 19 | 0.202 |
Negative | 46 | 103 |